the BRAIN - Shepherd Center
the BRAIN - Shepherd Center
the BRAIN - Shepherd Center
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Q+A<br />
ask <strong>the</strong> Doc<br />
<strong>Shepherd</strong> <strong>Center</strong> physicians answer medical questions from patients and family members.<br />
Q: What infertility problems are found in people with<br />
spinal cord injury?<br />
A: Most spinal cord injury (SCI) patients with infertility issues<br />
are men. Women may be concerned about obstetrical<br />
issues and complications – depending on whe<strong>the</strong>r <strong>the</strong>y<br />
have lung, kidney, neurologic and clotting problems. If<br />
women are over 35, <strong>the</strong> normal issues with achieving<br />
a pregnancy relate to age, ra<strong>the</strong>r than <strong>the</strong>ir SCI status.<br />
But if <strong>the</strong>re are medical concerns regarding carrying a<br />
pregnancy successfully, a gestational carrier (surrogate)<br />
can be used through in vitro fertilization (IVF).<br />
Men with SCI may have varying types of erectile<br />
dysfunction (ED) that may lead to infertility. It is important<br />
to have a semen analysis (SA) to determine what options<br />
are available for treatment. But many men with more<br />
extensive injuries may need to have electroejaculation<br />
(EEJ) to determine what treatment is indicated for<br />
achieving a pregnancy.<br />
If <strong>the</strong> SA is normal and <strong>the</strong> spouse is under age 35,<br />
ovulation induction with Clomid can be used with<br />
intrauterine inseminations (IUI) with a success rate<br />
of 8 to 12 percent per cycle. If <strong>the</strong> woman is over 35,<br />
medications may need to be more extensive with<br />
injectable drugs that can increase results up to 20<br />
percent. EEJ can cause concern because it may have<br />
to be done under anes<strong>the</strong>sia, and repeated procedures<br />
may irritate <strong>the</strong> rectal mucosa.<br />
Most couples in <strong>the</strong>se situations should do IVF so an EEJ<br />
may be done only once, if possible. The success rate can<br />
be 45 to 50 percent, depending on <strong>the</strong> woman’s age. If<br />
sperm aspiration or testicular sperm extraction (TESE) is<br />
needed due to a failed EEJ or extremely low sperm count,<br />
IVF is <strong>the</strong> only option for achieving a pregnancy.<br />
When a couple is considering a pregnancy with known<br />
issues, <strong>the</strong>y should consult with a urologist specializing<br />
in male infertility. This may be done in combination with<br />
a reproductive endocrinologist and infertility specialist.<br />
Each case is individualized. Overall, pregnancy rates are<br />
excellent, and if IVF is considered, most couples will have<br />
a sufficient number of embryos stored to complete <strong>the</strong>ir<br />
family with one cycle if all factors are optimal.<br />
— Dorothy Mitchell-Leef, M.D.<br />
Q: Do I really need to start one of <strong>the</strong> injectable medications if I've<br />
just been diagnosed with relapsing-remitting MS? Can’t I just<br />
wait and see how things go over <strong>the</strong> next couple of years?<br />
A: There are several reasons to strongly consider starting an injectable<br />
medication soon after a diagnosis of relapsing-remitting MS.<br />
1) Nerve fiber damage may occur early in MS. For years, MS was<br />
thought to involve mainly damage to <strong>the</strong> insulation (myelin) of <strong>the</strong><br />
nerve fibers (axons) in <strong>the</strong> brain and/or spinal cord. This is referred to<br />
as demyelination. In 1998, researchers confirmed that MS also can<br />
damage axons <strong>the</strong>mselves. This damage is permanent and leads to<br />
disability. It has been shown to occur early in MS. Starting<br />
an injectable MS <strong>the</strong>rapy early may help prevent this.<br />
2) MS changes over time. Without treatment, most people with<br />
relapsing-remitting MS will move toward secondary progressive<br />
MS. This form of MS does not respond well to currently approved<br />
<strong>the</strong>rapies and is characterized by a steady accumulation of disability.<br />
Starting treatment early may slow or prevent this move from<br />
relapsing-remitting to secondary progressive MS.<br />
3) While benign forms of MS exist, we are not good at predicting who<br />
might follow a milder course. We have some clues in early MS that<br />
may point toward someone doing well versus someone who’s<br />
going to have a more aggressive course, but most MS healthcare<br />
providers would not feel confident enough in <strong>the</strong>m to recommend<br />
absolutely against starting <strong>the</strong>rapy. — Ben Thrower, M.D.<br />
contributors<br />
Submit your questions for “Ask <strong>the</strong> Doc”<br />
to jane_sanders@shepherd.org or via<br />
fax at 404-350-3145<br />
Dorothy Mitchell-Leef, M.D.,<br />
<strong>Shepherd</strong> consulting physician,<br />
reproductive endocrinologist<br />
and infertility<br />
specialist with Reproductive<br />
Biology Associates<br />
Ben Thrower, M.D., medical<br />
director of <strong>the</strong> Andrew C.<br />
Carlos Multiple Sclerosis<br />
Institute at <strong>Shepherd</strong> <strong>Center</strong><br />
2 4 Spinal Column<br />
w w w. s h e p h e r d . o r g